| Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade S Magwenzi, C Woodward, KS Wraith, A Aburima, Z Raslan, H Jones, ... Blood, The Journal of the American Society of Hematology 125 (17), 2693-2703, 2015 | 180 | 2015 |
| cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway A Aburima, KS Wraith, Z Raslan, R Law, S Magwenzi, KM Naseem Blood, The Journal of the American Society of Hematology 122 (20), 3533-3545, 2013 | 130 | 2013 |
| Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade W Roberts, S Magwenzi, A Aburima, KM Naseem Blood, The Journal of the American Society of Hematology 116 (20), 4297-4306, 2010 | 105 | 2010 |
| Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathways KS Wraith, S Magwenzi, A Aburima, Y Wen, D Leake, KM Naseem Blood, The Journal of the American Society of Hematology 122 (4), 580-589, 2013 | 94 | 2013 |
| Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects H Kahal, A Halama, A Aburima, AM Bhagwat, AE Butler, J Graumann, ... Scientific reports 10 (1), 4750, 2020 | 90 | 2020 |
| The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls H Kahal, A Aburima, T Ungvari, AS Rigby, AM Coady, RV Vince, RA Ajjan, ... BMC endocrine disorders 15, 1-9, 2015 | 68 | 2015 |
| Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets A Aburima, M Berger, BEJ Spurgeon, BA Webb, KS Wraith, M Febbraio, ... Blood, The Journal of the American Society of Hematology 137 (5), 678-689, 2021 | 53 | 2021 |
| Nitric oxide inhibits von Willebrand factor‐mediated platelet adhesion and spreading through regulation of integrin αIIbβ3 and myosin light chain W Roberts, A Michno, A Aburima, KM Naseem Journal of Thrombosis and Haemostasis 7 (12), 2106-2115, 2009 | 45 | 2009 |
| Multiplexed phosphospecific flow cytometry enables large‐scale signaling profiling and drug screening in blood platelets BEJ Spurgeon, A Aburima, NG Oberprieler, K Taskén, KM Naseem Journal of Thrombosis and Haemostasis 12 (10), 1733-1743, 2014 | 42 | 2014 |
| cGMP signaling inhibits platelet shape change through regulation of the RhoA‐Rho Kinase‐MLC phosphatase signaling pathway A Aburima, K Walladbegi, JD Wake, KM Naseem Journal of Thrombosis and Haemostasis 15 (8), 1668-1678, 2017 | 39 | 2017 |
| Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome MM Aye, ES Kilpatrick, A Aburima, KS Wraith, S Magwenzi, B Spurgeon, ... Journal of the american heart association 3 (1), e000706, 2014 | 35 | 2014 |
| Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity H Kahal, A Aburima, T Ungvari, AS Rigby, AJ Dawson, AM Coady, ... Clinical Endocrinology 79 (2), 252-258, 2013 | 33 | 2013 |
| Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A M Berger, Z Raslan, A Aburima, S Magwenzi, KS Wraith, BEJ Spurgeon, ... haematologica 105 (3), 808, 2020 | 30 | 2020 |
| Platelet releasate promotes skeletal myogenesis by increasing muscle stem cell commitment to differentiation and accelerates muscle regeneration following acute injury D Scully, P Sfyri, S Verpoorten, P Papadopoulos, MC Muñoz‐Turrillas, ... Acta Physiologica 225 (3), e13207, 2019 | 29 | 2019 |
| Platelet function following induced hypoglycaemia in type 2 diabetes H Kahal, A Aburima, B Spurgeon, KS Wraith, AS Rigby, T Sathyapalan, ... Diabetes & metabolism 44 (5), 431-436, 2018 | 28 | 2018 |
| Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability MZ Yusuf, Z Raslan, L Atkinson, A Aburima, SG Thomas, KM Naseem, ... Scientific Reports 7 (1), 5582, 2017 | 28 | 2017 |
| Targeting of type I protein kinase A to lipid rafts is required for platelet inhibition by the 3′, 5′‐cyclic adenosine monophosphate‐signaling pathway Z Raslan, S Magwenzi, A Aburima, K Taskén, KM Naseem Journal of Thrombosis and Haemostasis 13 (9), 1721-1734, 2015 | 23 | 2015 |
| The spatiotemporal regulation of cAMP signaling in blood platelets—Old friends and new players Z Raslan, A Aburima, KM Naseem Frontiers in pharmacology 6, 266, 2015 | 22 | 2015 |
| Reversal of stress fibre formation by Nitric Oxide mediated RhoA inhibition leads to reduction in the height of preformed thrombi L Atkinson, MZ Yusuf, A Aburima, Y Ahmed, SG Thomas, KM Naseem, ... Scientific reports 8 (1), 3032, 2018 | 21 | 2018 |
| Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide R Riba, B Patel, A Aburima, KM Naseem Journal of Thrombosis and Haemostasis 6 (12), 2121-2131, 2008 | 20 | 2008 |
